KARISSA PLUMMER: Open Payments
NPI 1063834331 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$164 in 9 payments from 5 companies in 2025. Trend: 2023 $95 · 2024 $215 · 2025 $164
Food & beverage: $164
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $73 |
| ABBVIE INC. | 2 | $40 |
| Gilead Sciences, Inc. | 1 | $22 |
| Amgen Inc. | 1 | $14 |
| Lilly USA, LLC | 1 | $14 |
Products named: Rybelsus, AVYCAZ, Wegovy, DALVANCE, Saxenda, EVENITY, MOUNJARO.
Industry payments across CA — which companies pay providers there.
